跳至主要内容
临床试验/CTRI/2024/08/072607
CTRI/2024/08/072607尚未招募3 期

Efficacy of prophylactic unfiltered sunlight exposure in neonates more than 35 weeks of gestation on need of phototherapy for neonatal jaundice: A parallel group Randomised Control trial.

SUDIPTA SAHOO1 个研究点 分布在 1 个国家目标入组 560 人开始时间: 2024年9月5日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
560
试验地点
1
主要终点
Proportion of babies requiring phototherapy

研究概览

简要总结

Introduction:

Neonatal jaundice is one of the most common clinical conditions encountered during neonatal period, characterized by yellowish discoloration of skin and sclera due to an increase in serum bilirubin. It can affect up to 60% of term and 80% of preterm neonates. This transient increase in serum bilirubin is multifactorial in aetiology, with immaturity of foetal liver and increased bilirubin production being the most important contributing factors. Other factors like inadequate breast feeding, dehydration and sepsis can also cause elevation in bilirubin. This is usually self-resolving, improving with liver maturity of the baby. However, a significant elevation can result in bilirubin crossing the blood brain barrier and deposition in various regions like basal ganglia, resulting in various acute and long-term effects of the same.

Phototherapy has long been used as a highly effective modality of treatment of neonatal jaundice. Phototherapy employs the principle of photo isomerisation of insoluble unconjugated bilirubin to a soluble product, which can be excreted by the kidneys without any requirement of conjugation by the liver. Blue- green light, in the range of 420-490 nanometres wavelength, is the most effective spectrum in photo isomerisation reaction.

In a low middle income country (LMIC) like India, administration of phototherapy may not be feasible at peripheral centres and also imposes a large financial burden. The blue- green spectrum present in natural sunlight could be potentially used for this purpose, to induce photo isomerisation of unconjugated bilirubin and reduce the serum bilirubin to safe levels. There is scant literature regarding employing sunlight for prevention or treatment of neonatal hyperbilirubinemia, though the existing studies suggest that prophylactic sunlight exposure may hold promise as a natural and cost-effective alternative to reduce the incidence and severity of neonatal jaundice, potentially minimizing the need for phototherapy. While the potential benefits of sunlight exposure are intriguing, comprehensive studies are essential to ascertain its efficacy and safety in a clinical setting.

This study aims to investigate the prophylactic use of sunlight exposure as a preventive measure against neonatal jaundice and, consequently, as a means to reduce the need for phototherapy in newborns. Additionally, we will assess the safety profile of sunlight exposure in newborns.

The significance of this research lies in its potential to offer a natural and accessible alternative source, particularly in resource-limited settings where access to medical interventions may be constrained. If proven effective, prophylactic sunlight exposure could not only reduce the burden on healthcare systems but also contribute to improved neonatal outcomes and overall infant well-being. As we embark on this study, the results may pave the way for innovative and holistic approaches to neonatal care, emphasizing the importance of harnessing the potential of nature in promoting the health and well-being of our youngest population.

Rationale

In low and middle-income country (INDIA), babies are at increased risk for jaundice for a number of reasons, poor access to maternal care during antenatal period, increased blood disorders causing jaundice, increased risk of infection, birth trauma. Sunlight emits light in a similar spectrum as of phototherapy. Sunlight is readily available, there is need to determine its efficacy in reducing the need of phototherapy. In low and middle-income countries phototherapy is not always available for babies who need it. Lack of robust evidence on usage of sunlight for prevention of neonatal jaundice.

Novelty

To best of our knowledge this is the first RCT on this topic in our country, exploring the preventive effects of sunlight on reducing the risk of significant neonatal jaundice and requirement of phototherapy.

Expected outcome and application

 We expect the exposure of sunlight will prevent the occurrence of rate of significant neonatal jaundice needing intervention.

 Research question(s):

 In neonates ≥350/7 weeks (P), Does unfiltered sunlight exposure for 30 minutes, twice a day (I), compared to standard care (C), reduce the proportion of neonates requiring phototherapy (O)?

 Research hypothesis:

 Sunlight exposure for 30minutes, twice a day will reduce need of phototherapy in neonates of ≥35weeks.

 Aim and objectives:

 Aim:

To evaluate the efficacy of prophylactic unfiltered sunlight exposure in reduction of neonatal jaundice requiring phototherapy.

             Objectives:

 Primary objective(s)

 To evaluate the efficacy of exposure of sunlight twice a day for half an hour in reducing the requirement of phototherapy till discharge or 5 days whichever is earlier, in neonates of ≥35 weeks of gestation when compared to standard care.

 Secondary objective(s)

To study the

1.      Adverse effects associated   with sunlight exposure (hyperthermia, hypothermia, dehydration)

2.      Need of exchange transfusion, Duration of phototherapy.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
0.00 Day(s) 至 1.00 Day(s)(—)
性别
All

入选标准

  • All inborn, hemodynamically stable neonates of gestation ≥35weeks.
  • Acceptance of the study by the parents by a valid informed consent.

排除标准

  • Babies requiring NICU admission.
  • Babies having cephalohematoma or subgaleal haematoma.
  • Babies having major congenital anomalies.
  • Iso immune haemolytic anaemia.

结局指标

主要结局

Proportion of babies requiring phototherapy

时间窗: 5 days or discharge, whichever later

次要结局

  • Incidence of Hyperthermia(At 15 and 30 minutes of exposure)
  • Incidence of Hypothermia(At 15 and 30 minutes of exposure)
  • Proportion of babies having dehydration(48 hours)
  • Proportion of babies requiring exchange transfusion(5 days)
  • Duration of(phototherapy (in hours) needed)

研究者

发起方
SUDIPTA SAHOO
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

SUDIPTA SAHOO

AIIMS, Patna

研究点 (1)

Loading locations...

相似试验